Close Menu

NEW YORK – PerkinElmer said after the close of the market on Tuesday it is offering $850 million in aggregate principal 3.3 percent senior notes due in 2029.

The notes will be issued at 99.67 percent of the principal amount and the issuance is expected to close on Sept. 12. The notes will pay interest semi-annually.

The book-running managers for the offering are JP Morgan and Bank of America Securities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.